| Author (Corporate) | European Court of Justice: Press and Information Division |
|---|---|
| Series Title | Press Release |
| Series Details | No.06, 2018 (23.01.18) |
| Publication Date | 23/01/2018 |
| Content Type | News |
|
The agreement between the pharmaceutical groups Roche and Novartis designed to reduce the use of Avastin in ophthalmology and to increase the use of Lucentis might constitute a restriction of competition ‘by object’. |
|
| Source Link | Link to Main Source https://curia.europa.eu/jcms/upload/docs/application/pdf/2018-01/cp180006en.pdf |
| Subject Categories | Internal Markets, Law |
| Countries / Regions | Italy |
